Jeff Berkowitz is a former Executive Vice President of UnitedHealth Group/Optum where he led Optum’s International division as CEO. Prior to joining UnitedHealth Group, Jeff served as the President of Pharma and Global Market Access for the Walgreens Boots Alliance. While at the Walgreens Boots Alliance Jeff also served as President of Walgreens Boots Alliance Development GmbH, where he was based in Bern, Switzerland for three years leading the global health and well being efforts as the senior-most Walgreens executive residing outside of the U.S.
Prior to joining Walgreens in September 2010, Jeff was senior vice president of global market access for Merck & Company, where he was a member of the Global Human Health and Emerging Markets leadership teams. From 2002 to 2009, Jeff held a variety of positions with increasing responsibility in market access, sales and marketing with Schering-Plough prior to its acquisition by Merck in 2009.
Before joining Schering-Plough, Jeff was a health care attorney for the international law firm Proskauer LLP. Jeff currently serves on the board of directors of H. Lundbeck A/S, Esperion Therapuetics, Inc. and Infinity Pharmaceuticals, Inc. as well as ZappRx a specialty pharmacy services company. Jeff also served on the Board of Directors of the Swiss-American Chamber of Commerce. He has been recognized three times in PharmaVoice magazine as one of the 100 Most Inspiring Leaders in the Life Sciences.
Jeff earned his bachelor’s degree in political science from Union College in Schenectady, N.Y., and his Juris Doctor from Brooklyn Law School in Brooklyn, N.Y. When not working, Jeff travels extensively with his wife and three kids and has traveled through more then sixty countries.